Tags

Type your tag names separated by a space and hit enter

Synthesis and characterization of chitosan/ZnO nanoparticle composite membranes.
Carbohydr Res. 2010 May 27; 345(8):994-8.CR

Abstract

Novel chitosan/ZnO nanoparticle (CS/nano-ZnO) composite membranes were prepared via the method of sol-cast transformation and studied by UV-vis absorption spectroscopy (UV-vis), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and energy dispersive X-ray fluorescence spectrometry (EDX). The characterization revealed that ZnO nanoparticles dispersed homogeneously within the chitosan matrix. The mechanical and antibacterial properties of the product were investigated. The results showed that the ZnO content had an effect on the mechanical properties of CS/nano-ZnO composite membranes, and that the antibacterial activities of CS membranes for Bacillus subtilis, Escherichia coli, and Staphylococcus aureus were enhanced by the incorporation of ZnO. Further, CS/nano-ZnO composite membranes with 6-10 wt% ZnO exhibited high antibacterial activities.

Links

Publisher Full Text

Authors+Show Affiliations

Li LH
College of Chemistry, Xiangtan University, Key Laboratory of Environmentally Friendly Chemistry and Applications of Ministry of Education, Xiangtan 411105, Hunan, China.
Deng JC
No affiliation info available
Deng HR
No affiliation info available
Liu ZL
No affiliation info available
Xin L
No affiliation info available

MeSH

Bacillus subtilisChitosanEscherichia coliMicroscopy, Electron, ScanningNanocompositesNanoparticlesSpectrometry, X-Ray EmissionSpectroscopy, Fourier Transform InfraredStaphylococcus aureusX-Ray DiffractionZinc Oxide

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20371037

Citation

Li, Li-Hua, et al. "Synthesis and Characterization of chitosan/ZnO Nanoparticle Composite Membranes." Carbohydrate Research, vol. 345, no. 8, 2010, pp. 994-8.
Li LH, Deng JC, Deng HR, et al. Synthesis and characterization of chitosan/ZnO nanoparticle composite membranes. Carbohydr Res. 2010;345(8):994-8.
Li, L. H., Deng, J. C., Deng, H. R., Liu, Z. L., & Xin, L. (2010). Synthesis and characterization of chitosan/ZnO nanoparticle composite membranes. Carbohydrate Research, 345(8), 994-8. https://doi.org/10.1016/j.carres.2010.03.019
Li LH, et al. Synthesis and Characterization of chitosan/ZnO Nanoparticle Composite Membranes. Carbohydr Res. 2010 May 27;345(8):994-8. PubMed PMID: 20371037.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Synthesis and characterization of chitosan/ZnO nanoparticle composite membranes. AU - Li,Li-Hua, AU - Deng,Jian-Cheng, AU - Deng,Hui-Ren, AU - Liu,Zi-Ling, AU - Xin,Ling, Y1 - 2010/03/19/ PY - 2009/12/03/received PY - 2010/03/06/revised PY - 2010/03/16/accepted PY - 2010/4/8/entrez PY - 2010/4/8/pubmed PY - 2010/7/27/medline SP - 994 EP - 8 JF - Carbohydrate research JO - Carbohydr Res VL - 345 IS - 8 N2 - Novel chitosan/ZnO nanoparticle (CS/nano-ZnO) composite membranes were prepared via the method of sol-cast transformation and studied by UV-vis absorption spectroscopy (UV-vis), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and energy dispersive X-ray fluorescence spectrometry (EDX). The characterization revealed that ZnO nanoparticles dispersed homogeneously within the chitosan matrix. The mechanical and antibacterial properties of the product were investigated. The results showed that the ZnO content had an effect on the mechanical properties of CS/nano-ZnO composite membranes, and that the antibacterial activities of CS membranes for Bacillus subtilis, Escherichia coli, and Staphylococcus aureus were enhanced by the incorporation of ZnO. Further, CS/nano-ZnO composite membranes with 6-10 wt% ZnO exhibited high antibacterial activities. SN - 1873-426X UR - https://www.unboundmedicine.com/medline/citation/20371037/Synthesis_and_characterization_of_chitosan/ZnO_nanoparticle_composite_membranes_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0008-6215(10)00115-1 DB - PRIME DP - Unbound Medicine ER -